Cargando…

Systematic profiling of a lipid metabolism‐derived signature guides risk‐stratification and therapeutic strategies in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Zhu, Zhengyi, Chen, Yuyan, Xia, Jinkun, Wang, Jinglin, Ren, Haozhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172611/ https://www.ncbi.nlm.nih.gov/pubmed/37165598 http://dx.doi.org/10.1002/ctm2.1254

Ejemplares similares

FOXO1 regulates Th17 cell-mediated hepatocellular carcinoma recurrence after hepatic ischemia-reperfusion injury
por: Ren, Haozhen, et al.
Publicado: (2023)

Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Is a Promising Signature to Predict Prognosis and Therapies for Hepatocellular Carcinoma (HCC)
por: Chen, Yuyan, et al.
Publicado: (2023)

C-Type Lectin Receptors-Triggered Antifungal Immunity May Synergize with and Optimize the Effects of Immunotherapy in Hepatocellular Carcinoma
por: Xia, Jinkun, et al.
Publicado: (2023)

Optimal risk stratification and therapeutic strategy for acute myocardial infarction
por: Imamura, Teruhiko
Publicado: (2021)

Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition
por: Zhou, Yuan, et al.
Publicado: (2020)

Extracellular HMGB1 promotes CD44 expression in hepatocellular carcinoma via regulating miR-21
por: Li, Jun, et al.
Publicado: (2021)

Reply to the Letter to the Editor Entitled “Optimal risk stratification and therapeutic strategy for acute myocardial infarction”
por: Wang, Sheng‐ji, et al.
Publicado: (2021)

Hepatic spheroids derived from human induced pluripotent stem cells in bio-artificial liver rescue porcine acute liver failure
por: Chen, Sitong, et al.
Publicado: (2019)

Down-Regulation of CXXC5 De-Represses MYCL1 to Promote Hepatic Stellate Cell Activation
por: Wu, Xiaoyan, et al.
Publicado: (2021)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

Comprehensive Metabolic Profiling and Genome-wide Analysis Reveal Therapeutic Modalities for Hepatocellular Carcinoma
por: Qi, Feng, et al.
Publicado: (2023)

MT4‐MMP in tumor‐associated macrophages is linked to hepatocellular carcinoma aggressiveness and recurrence
por: Qi, Feng, et al.
Publicado: (2020)

An Immune Signature for Risk Stratification and Therapeutic Prediction in Helicobacter pylori-Infected Gastric Cancer
por: Geng, Haigang, et al.
Publicado: (2022)

Epiregulin (EREG) and Myocardin Related Transcription Factor A (MRTF-A) Form a Feedforward Loop to Drive Hepatic Stellate Cell Activation
por: Wu, Xiaoyan, et al.
Publicado: (2021)

Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis
por: Yang, Faji, et al.
Publicado: (2019)

Comprehensive proteomic profiling of serum extracellular vesicles in patients with colorectal liver metastases identifies a signature for non-invasive risk stratification and early-response evaluation
por: Lin, Kuailu, et al.
Publicado: (2022)

Genomewide transcriptomic profiling identifies a gene signature for predicting recurrence in early‐stage hepatocellular carcinoma
por: Kakisaka, Tatsuhiko, et al.
Publicado: (2021)

Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype
por: Wang, Jinglin, et al.
Publicado: (2022)

Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis
por: Zhou, Yan, et al.
Publicado: (2022)

Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair‐based signature
por: Lu, Xiaofan, et al.
Publicado: (2021)

Performance of the coronary calcium score in an outpatient chest pain clinic and strategies for risk stratification
por: Huang, Weiting, et al.
Publicado: (2021)

Inhibition of HMGB1 Suppresses Hepatocellular Carcinoma Progression via HIPK2-Mediated Autophagic Degradation of ZEB1
por: Zhu, Wei, et al.
Publicado: (2021)

A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)

Yoga and lipid profile
por: Wiwanitkit, Viroj
Publicado: (2011)

Mesenchymal stem cell-secreted prostaglandin E(2) ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization
por: Wang, Jinglin, et al.
Publicado: (2021)

Antibiotic pretreatment attenuates liver ischemia–reperfusion injury by Farnesoid X receptor activation
por: Liu, Hanyi, et al.
Publicado: (2022)

Correction: Mesenchymal stem cell-secreted prostaglandin E2 ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization
por: Wang, Jinglin, et al.
Publicado: (2023)

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
por: Lin, Zhu, et al.
Publicado: (2023)

Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)

Risk Stratification to Guide Prevention and Control Strategies for Arboviruses Transmitted by Aedes aegypti
por: Espinosa, Manuel Osvaldo, et al.
Publicado: (2023)

A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Xu, Kequan, et al.
Publicado: (2022)

The Issue of Tissue in Molecular Stratification
por: Tan, Min‐Han, et al.
Publicado: (2017)

A metastasis‐associated microRNA‐based liquid biopsy signature for risk‐stratification in colorectal cancer: a multicenter cohort study
por: Matsuyama, Takatoshi, et al.
Publicado: (2022)

Mutational Signatures Driven by Epigenetic Determinants Enable the Stratification of Patients with Gastric Cancer for Therapeutic Intervention
por: Buttura, Jaqueline Ramalho, et al.
Publicado: (2021)

Progress in therapeutic strategies based on cancer lipid metabolism
por: Diao, Xia‐Yao, et al.
Publicado: (2019)

A stratification model of hepatocellular carcinoma based on expression profiles of cells in the tumor microenvironment
por: Zeng, Chunting, et al.
Publicado: (2022)

A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma
por: Sun, Jianping, et al.
Publicado: (2023)

Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer
por: Lin, Yaobin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3fsisugpf08f3h9vh5jlpk622n